Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Outcome Of The Meeting Of Board Of Directors Held On 05.03.2021

 In continuation to our corporate disclosure dated 26th November,2020 and 02nd January, 2021, which were filed with exchange in due course and in line with the corporate disclosure requirement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that : Board of Directors of the Company had in its meeting held on 05.03.2021 has approved the change in consideration and also extended the date of completion to 31.03.2021 for completion of sale / disposal in pursuant to Share Purchase Agreement (SPA) executed with Asence Pharma Private Limited for sale of equity shares of Synbiotics Limited, a wholly owned subsidiary to Asence Pharma Private Limited, another subsidiary of the Company on revised consideration. The detailed announcement has been attached herewith. Please take on your record and oblige.
05-03-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Results - Financial Result For The Quarter And Nine Months Ended 31.12.2020 Along With Limited Review Report Thereon.

 Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 12th February, 2021, has considered, approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine months ended on 31st December,2020 along with Limited Review Report by Auditors thereon.
12-02-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - OUTCOME OF THE BOARD MEETING HELD ON 12.02.2021

 Following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 12th February, 2021: 1. Approval of Financial results for the quarter and nine months ended 31.12.2020 (Standalone & Consolidated) along with limited review report. 2. Re-appointment of Mr. Kartikeya V. Sarabhai (DIN:00313585) as Chairman & Whole-time Director for the period of 3 years w.e.f. 1st April, 2021, subject to approval of the members of the Company at ensuing General Meeting. 3. Re-appointment of Ms. Chaula Shastri (DIN: 06404118) as Whole-time Director for the period of 3 years w.e.f. 1st April, 2021, subject to approval of the members of the Company at ensuing General Meeting. 4. Appointment of M/s. Rajesh Parekh & Co., Practising Company Secretaries, Ahmedabad as Secretarial Auditor of the Company for the financial year 2020-21.
12-02-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2020

 AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve To consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine months ended on December 31, 2020 and any other matter as the Board of Directors of the Company may decide during the course of the meeting. We hereby enclose the intimation for your reference.
05-02-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Shareholding for the Period Ended December 31, 2020

 Ambalal Sarabhai Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
16-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, the Registrar and Transfer Agent of the Company for the period ended on 31st December, 2020. You are requested to take on your record and oblige.
15-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DAMODAR H SEJPALDesignation :- Company Secretary and Compliance Officer
15-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Reply On Clarification For Significant Movement In Price

 With reference to significant movement in price, we are hereby enclosing the reply to the clarification sought by the stock exchange with reference to the significant movement in the price of the securities of the Company. Please take on your record and oblige.
08-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Clarification sought from Ambalal Sarabhai Enterprises Ltd

 The Exchange has sought clarification from Ambalal Sarabhai Enterprises Ltd on January 07, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
07-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Outcome Of The Meeting Of Board Of Directors Held On 02.01.2021

 In continuation to our corporate disclosure dated 26th November,2020 which was filed with exchange on 26th November,2020 and in line with the corporate disclosure requirement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that : Board of Directors of the Company had in its meeting held on 2nd January,2021, inter-alia, has approved the extension up to 28.02.2021 for completion of sale / disposal in pursuant to Share Purchase Agreement (SPA) executed with Asence Pharma Private Limited for sale of equity shares of Synbiotics Limited, a wholly owned subsidiary to Asence Pharma Private Limited, another subsidiary of the Company on consideration of Rs. 11,91,87,640/-(Rupees Eleven Crores Ninety One Lakh Eighty Seven Thousand Six Hundred Forty only). The detailed announcement has been attached herewith. Please take on your record and oblige.
02-01-2021
Next Page
Close

Let's Open Free Demat Account